About: http://data.cimple.eu/news-article/e923d8f6c318e285af064fe47d3fa563fe72eb59fb511c2c3835b993     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

AttributesValues
rdf:type
schema:articleBody
  • British pharmaceutical group GlaxoSmithKline and German biotech firm CureVac on Wednesday announced plans to jointly develop a coronavirus vaccine with the potential to counter multi-variants of Covid-19. "The development programme will begin immediately, with the target of introducing the vaccine in 2022, subject to regulatory approval," a joint statement said. GSK will also support the manufacture this year of up to 100 million doses of CureVac's first generation Covid-19 vaccine, it added. The collaboration, building on an existing relationship, is to develop next generation Covid-19 vaccines "with the potential for a multi-valent approach to address multiple emerging variants in one vaccine". The pair noted that "the increase in emerging variants with the potential to reduce the efficacy of first generation Covid-19 vaccines requires acceleration of efforts to develop vaccines against new variants to keep one step ahead of the pandemic". GSK chief executive Emma Walmsley said "next generation vaccines will be crucial in the continued fight against Covid-19". The value of the new collaboration was put at 150 million euros ($181 million). "We are very pleased to build on our existing relationship with GSK with a new agreement," said CureVac chief executive Franz-Werner Haas. "With the help of GSK's proven vaccine expertise, we are equipping ourselves to tackle future health challenges with novel vaccines." bcp/bmm
schema:headline
  • GSK, CureVac say to develop vaccine against Covid variants
schema:mentions
schema:author
schema:datePublished
http://data.cimple...sPoliticalLeaning
http://data.cimple...logy#hasSentiment
http://data.cimple...readability_score
http://data.cimple...tology#hasEmotion
Faceted Search & Find service v1.16.115 as of Oct 09 2023


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software